Demin Li
PhD, MBBS, MSc
Visiting Scientist
- Senior Research Fellow
Understanding immune recognition and developing cancer immunotherapy.
Recent publications
-
Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens.
Journal article
Ternette N. et al, (2018), Proteomics, 18, e1700465 - e1700465
-
Therapeutic antibodies against intracellular tumor antigens
Journal article
Trenevska I. et al, (2017), Frontiers in Immunology
-
Engineering chimeric Human and Mouse Major Histocompatibility Complex (MHC) Class I Tetramers for the Production of T-Cell Receptor (TCR) Mimic Antibodies
Journal article
Li D. et al, (2017), PLoS One
-
Development of a T Cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy.
Journal article
Li D. et al, (2017), Cancer Res
-
The European antibody network's practical guide to finding and validating suitable antibodies for research.
Journal article
Roncador G. et al, (2016), MAbs, 8, 27 - 36
ORCID
0000-0002-7118-3401